Ms. Sandoval currently serves as a consultant to the pharmaceutical industry and is a member of the board of directors of Intersect ENT, Inc., Satsuma Pharmaceuticals, Inc. and Vyne Therapeutics, Inc. She is also on the Board of privately held Alastin Skincare. Ms. Sandoval previously served as the Chief Commercial Officer and Executive Vice President of Corporate Strategy at Alder Biopharmaceuticals. She was Chief Commercial Officer for Kythera Biopharmaceuticals and spent over 20 years at Allergan in a variety of commercial leadership roles of increasing responsibility. Ms. Sandoval holds a B.S. in Biology from University of California at Irvine and an M.B.A. from Pepperdine University, The George L. Graziadio School of Business and Management.
Reza Zadno, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER
Dr. Zadno has served as PROCEPT BioRobotics President and Chief Executive Officer and a member of the board of directors since February 2020. Prior to joining PROCEPT BioRobotics Dr. Zadno served as President and Chief Executive Officer of Avedro, Inc., an ophthalmology company that developed a proprietary Corneal Remodeling Platform Technology. During his time at Avedro, Inc. from September 2016 to November 2020, he led the company through an IPO and rapid commercialization, and ultimately an acquisition by Glaukos; he also served as a member of the board of directors at Avedro. Prior to Avedro, Dr. Zadno served as Innovation Advisor and Venture Partner at InterWest Partners, a venture capital firm, from January 2012 to January 2018. Dr. Zadno has also served on the boards of directors of Invuity, Inc. from January 2013 to June 2017, where he was a member of the audit committee, and Carbylan Therapeutics, Inc. from June 2013 to November 2016, where he was a member of the audit committee. Dr. Zadno also served on the Board of a number of additional private companies. Dr. Zadno also co-founded PercuSurge, a maker of distal protection devices used in treating occluded carotid arteries and saphenous vein grafts, which was acquired by Medtronic. Dr. Zadno received both a Ph.D. and an M.Sc. in Mechanical Properties of Materials from École Nationale Supérieure des Mines de Paris.